Meloxicam in Combating Clinical Mastitis: Nanotechnology-Driven Hope and Opportunities

Mastitis has well-recognized harmful effects on dairy farm profitability. Furthermore, mastitis impairs the milk component synthesizing ability of secretary tissues. Various therapies are available for the treatment of clinical mastitis. Meloxicam exhibits preferential binding to Cyclooxygenase-2 (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Jyothi, Vaskuri G. S. Satya Sainaga, Babu, Chanti Katta, Kumar, Rahul, Singh, Pankaj Kumar, Khatri, Dharmendra Kumar, Singh, Shashi Bala, Madan, Jitender
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728067/
https://www.ncbi.nlm.nih.gov/pubmed/36506727
http://dx.doi.org/10.4103/jpbs.jpbs_649_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9728067/
https://www.ncbi.nlm.nih.gov/pubmed/36506727
http://dx.doi.org/10.4103/jpbs.jpbs_649_21

Ejemplares similares